Canopy Growth Corp T.WEED

Alternate Symbol(s): T.WEED.DB | CGC

Healthcare Cannabis

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.

TSX:WEED - Post by User

Canopy Growth Corp

Bullboard Posts

Post by aebestaceyon Jun 11, 2018 7:09pm

325 Views

Post# 28157124

Just the Facts .....

Canopy Growth Corp.

Toronto Stock Exchange:

WEED

New York Stock Exchange:

CGC

Legal Cannabis

Country:

Canada

Employees:

546 at 03/31/17

Established:

2012

CEO:

Bruce Linton

Number of Patients:

~63K

Headquarters:

Smith Falls, ON

Financials (12/31/17)

Cash on hand:

$237.8mm

Fixed Investment:

$154.0mm

Shareholders’ Equity:

$1.02 billion

Revenues – Last Quarter:

$21.7mm

Adj. Gross Margin:

57.8%

EPS:

0.01

Capital Structure (02/13/18)

Last Financing:

5.8mm shares w/warrants at $34.60

Basic Shares:

196.4mm

Warrants:

18.9mm

Options:

14.4mm

Diluted Shares:

229.7mm

Company Brief

Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.

Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates eight cannabis production sites with over 2.4 million square feet of production capacity, including over 500,000 square feet of GMP-certified production space.

The Company has operations in seven countries across four continents. The Company is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and through its partly owned subsidiary, Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development. Through partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment to new market entrants and building a portfolio of stable investments in the sector. From our historic public listing to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth.

Differentiators

Leading publicly-traded producer in terms of revenue, grams shipped and registered medical patients

Multiple production facilities in provinces including Alberta, British Columbia, Saskatchewan, Ontario, Qubec, New Brunswick, and Newfoundland

Indoor and greenhouse growing, multiple brands, and 45 quality strains of cannabis targeting medical (Bedrocan, Mettrum and Tweed), Health & Wellness (Mettrum) and recreational (Tweed) markets

First publicly-traded LP (April 2014) and first to attain listing on the Toronto Stock Exchange (August 2016).

Strategic partnerships with Snoop Dogg and DNA Genetics to develop proprietary brands and new strains

International alliances in multiple countries, including Australia, Brazil, Chile, Germany, Spain, and Denmark

Brick-and-mortar presence with Tweed Main Street, helping educate prospective patients, connect them with physicians and streamline registration

Canopy Rivers, a cannabis investment and operating platform

Canopy Health Innovations, a biopharmaceutical sister company focused on cannabis-based products